AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $8,000 | +14.3% | 242 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | -41.7% | 242 | -27.3% | 0.00% | -100.0% |
| Q2 2021 | $12,000 | -14.3% | 333 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | -6.7% | 340 | +2.1% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | +36.4% | 333 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $11,000 | +10.0% | 333 | -5.1% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | +11.1% | 351 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | -18.2% | 351 | +4.2% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | -31.2% | 337 | -22.9% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | +60.0% | 437 | +84.4% | 0.00% | 0.0% |
| Q2 2019 | $10,000 | 0.0% | 237 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,000 | +11.1% | 237 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | -43.8% | 237 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $16,000 | +14.3% | 237 | -4.8% | 0.00% | +100.0% |
| Q2 2018 | $14,000 | – | 249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |